Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03333252 · ClinicalTrials.gov registry record · NA

A Non-pharmacological Intervention for Patients With Alzheimer's Disease and Family Caregivers (Care Partners Program)

A NA study, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
352
Enrollment target

NCT03333252 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 352 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03333252, a NA study, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
352 participants
Enrollment target

Study Summary

The proposed study will develop and test the efficacy and feasibility of a dyadic-based intervention program (DT), delivered through state-of-the art computer tablet technology. A novel feature of the investigation is its focus on both the caregiver and the recipient of care (person with AD) and the integration of an evidenced-based caregiver intervention and evidenced-based cognitive/functional training for the care recipient. The program will be tailored for the caregiver and emphasize issues important to caregivers, not only in the earlier stages of caregiving, but will also target issues across the caregiving trajectory to help prepare the caregiver for changes in their role. Two hundred and forty Hispanic, African American and White/Caucasian dyads will be randomized to the DT intervention or Control condition. Measures at baseline and the 6 and 12-month follow-ups will include indices of care recipient processing speed and quality of life, and caregiver outcomes such as; depression, burden, self-care activities and social support . Information will also be gathered on ethnic differences in response to the intervention and estimates of cost effectiveness of the intervention.

Interventions

  • BEHAVIORAL Control Condition
  • BEHAVIORAL Intervention Condition

Trial Details

FieldValue
Enrollment Target 352 participants
Start Date 2018-01-29
Est. Completion 2023-05-01
Phase NA

What the Registry Record Tells You About NCT03333252

The ClinicalTrials.gov registry entry for NCT03333252 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 352 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control Condition is the first listed.

NCT03333252 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03333252 about?

NCT03333252 is a clinical study titled "A Non-pharmacological Intervention for Patients With Alzheimer's Disease and Family Caregivers (Care Partners Program)". The proposed study will develop and test the efficacy and feasibility of a dyadic-based intervention program (DT), delivered through state-of-the art computer tablet technology. A novel feature of the investigation is its focus on both the caregiver and the recipient of care (person with AD) and the...

What is the current status of trial NCT03333252?

This trial is currently completed. It is a NA study. The enrollment target is 352 participants. The study started on 2018-01-29. Estimated completion is 2023-05-01.

What interventions are being tested in trial NCT03333252?

The interventions under investigation include: Control Condition (BEHAVIORAL), Intervention Condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT03333252?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.